Amblyopia treatment sales will expand through 2036, with pharmacies holding a 48.0% share in 2026 as the leading distribution channel segment. The market is expected to reach USD 4.12 billion in 2026 and USD 5.98 billion by 2036, creating an absolute opportunity of USD 1.86 billion between 2026 and 2036.